IMUGENE LIMITED — Share Issue/Capital Change 2020

May 14, 2020

==> picture [109 x 40] intentionally omitted <==

ASX Announcement

Release of Shares from Escrow

---

Sydney, Australia, 15 May 2020 : Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company wishes to advise of the upcoming release of ordinary shares from escrow.

In accordance with ASX listing rule 3.10A, Imugene Limited advises that 22,039,290 ordinary fully paid shares will be released from escrow on 27 May 2020.

Authorised by Phillip Hains, Company Secretary.

IMUGENE LIMITED ACN 009 179 551 WWW.IMUGENE.COM info@imugene.com